During the past decade, Centrum für Hämatologie und Onkologie Bethanien conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centrum für Hämatologie und Onkologie Bethanien" are "Advanced/Metastatic Breast Cancer" (1 trials), "Breast Cancer (Early Breast Cancer)" (1 trials), "Multiple Myeloma" (1 trials), "Newly Diagnosed" (1 trials) and "Patient Preference" (1 trials). Many other conditions were trialed in "Centrum für Hämatologie und Onkologie Bethanien" in a lesser frequency.

Most popular intervention types in "Centrum für Hämatologie und Onkologie Bethanien" are "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood sampling" (1 trials) and "Daratumumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centrum für Hämatologie und Onkologie Bethanien" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centrum für Hämatologie und Onkologie Bethanien". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centrum für Hämatologie und Onkologie Bethanien, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centrum für Hämatologie und Onkologie Bethanien, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".